Glintborg, B, Jensen, D V, Terslev, L, Hendricks, O, Østergaard, M, Rasmussen, S H, Jensen, M P, Adelsten, T, Colic, A, Danebod, K, Kildemand, M, Loft, A G, Munk, H L, Pedersen, J K, Østgård, R D, Sørensen, C M, Krogh, N S, Agerbo, J N, Ziegler, C & Hetland, M L 2022, ' Long-term Behavioral Changes During the COVID-19 Pandemic and Impact of Vaccination in Patients With Inflammatory Rheumatic Diseases ', Journal of Rheumatology, vol. 49, no. 10, pp. 1163-1172 . https://doi.org/10.3899/jrheum.211280
Vittrup, I, Krogh, N S, Larsen, H H P, Elberling, J, Skov, L, Ibler, K S, Jemec, G B E, Mortz, C G, Bach, R O, Bindslev-jensen, C, Dalager, M G, Egeberg, A, Agner, T, Deleuran, M, Vestergaard, C & Thyssen, J P 2023, ' A nationwide 104 weeks real-world study of dupilumab in adults with atopic dermatitis : Ineffectiveness in head-and-neck dermatitis ', Journal of the European Academy of Dermatology and Venereology, vol. 37, no. 5, pp. 1046-1055 . https://doi.org/10.1111/jdv.18849 Vittrup, I, Krogh, N S, Larsen, H H P, Elberling, J, Skov, L, Ibler, K S, Jemec, G B E, Mortz, C G, Bach, R O, Bindslev-Jensen, C, Dalager, M G, Egeberg, A, Agner, T, Deleuran, M, Vestergaard, C & Thyssen, J P 2023, ' A nationwide 104 weeks real-world study of dupilumab in adults with atopic dermatitis : Ineffectiveness in head-and-neck dermatitis ', Journal of the European Academy of Dermatology and Venereology, vol. 37, no. 5, pp. 1046-1055 . https://doi.org/10.1111/jdv.18849 Vittrup, I, Elberling, J, Skov, L, Ibler, K S, Jemec, G B E, Mortz, C G, Bindslev-Jensen, C, Agner, T, Deleuran, M, Vestergaard, C & Thyssen, J P 2023, ' A nationwide 104 weeks real-world study of dupilumab in adults with atopic dermatitis : ineffectiveness in head-and-neck dermatitis ', Journal of the European Academy of Dermatology and Venereology : JEADV . https://doi.org/10.1111/jdv.18849
Ørnbjerg, L M, Svensson, E, Løngaard, K, Meincke, R H, Pedersen, J K, Dreyer, L, Krogh, N S, Jensen, D V & Hetland, M L 2022, ' Conversion of the MDHAQ to the HAQ score-a simple algorithm developed and validated in a cohort of 13,391 real-world patients ', Rheumatology, vol. 61, no. 10, keac040, pp. 3919-3929 . https://doi.org/10.1093/rheumatology/keac040
Nabi, H, Hendricks, O, Jensen, D V, Loft, A G, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Chrysidis, S, Raun, J L, Andersen, M, Mehnert, F, Krogh, N S, Hetland, M L & Glintborg, B 2022, ' Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease : clinical outcomes in real-world patients from the DANBIO registry ', RMD Open, vol. 8, no. 2, e002560 . https://doi.org/10.1136/rmdopen-2022-002560 Nabi, H, Hetland, M L, Loft, A G, Hendricks, O, Jensen, D, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Grydehøj, J, Raun, J, Ahmed, R, Mehnert, F, Krogh, N S & Glintborg, B 2022, ' INFLIXIMAB BIOSIMILAR-TO-BIOSIMILAR SWITCHING IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: CLINICAL OUTCOMES IN REAL-WORLD PATIENTS FROM THE DANBIO REGISTRY ', Annals of the Rheumatic Diseases, vol. 81, no. Suppl. 1, OP0065, pp. 45-46 . https://doi.org/10.1136/annrheumdis-2022-eular.2306 Nabi, H, Hendricks, O, Jensen, D V, Loft, A G, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Chrysidis, S, Raun, J L, Andersen, M, Mehnert, F, Krogh, N S, Hetland, M L & Glintborg, B 2022, ' Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease : Clinical outcomes in real-world patients from the DANBIO registry ', RMD Open, vol. 8, no. 2, 002560 . https://doi.org/10.1136/rmdopen-2022-002560 Nabi, H, Hendricks, O, Jensen, D V, Loft, A G, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Chrysidis, S, Raun, J L, Andersen, M, Mehnert, F, Krogh, N S, Hetland, M L & Glintborg, B 2022, ' Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease : Clinical outcomes in real-world patients from the DANBIO registry ', RMD open, vol. 8, no. 2, 002560 . https://doi.org/10.1136/rmdopen-2022-002560
Møller-Bisgaard, S, Hørslev-Petersen, K, Ejbjerg, B, Hetland, M L, Christensen, R, Ørnbjerg, L M, Glinatsi, D, Møller, J M, Boesen, M, Stengaard-Pedersen, K, Madsen, O R, Jensen, B, Villadsen, J A, Hauge, E M, Bennett, P, Hendricks, O, Asmussen, K, Kowalski, M, Lindegaard, H, Bliddal, H, Krogh, N S, Ellingsen, T, Nielsen, A H, Larsen, L, Jurik, A G, Thomsen, H S & Østergaard, M 2022, ' Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial ', Scandinavian Journal of Rheumatology, vol. 51, no. 4, pp. 268-278 . https://doi.org/10.1080/03009742.2021.1935312 Møller-Bisgaard, S, Hørslev-Petersen, K, Ejbjerg, B, Hetland, M L, Christensen, R, Ørnbjerg, L M, Glinatsi, D, Møller, J M, Boesen, M, Stengaard-Pedersen, K, Madsen, O R, Jensen, B, Villadsen, J A, Hauge, E M, Bennett, P, Hendricks, O, Asmussen, K, Kowalski, M, Lindegaard, H, Bliddal, H, Krogh, N S, Ellingsen, T, Nielsen, A H, Larsen, L, Jurik, A G, Thomsen, H S & Østergaard, M 2022, ' Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission : Secondary analyses of the IMAGINE-RA trial ', Scandinavian Journal of Rheumatology, vol. 51, no. 4, pp. 268–278 . https://doi.org/10.1080/03009742.2021.1935312
Uhrenholt, L, Christensen, R, Dreyer, L, Schlemmer, A, Hauge, E M, Krogh, N S, Abildtoft, M K, Taylor, P C & Kristensen, S 2022, ' Using a novel smartphone application for capturing of patient-reported outcome measures among patients with inflammatory arthritis:A randomized, crossover, agreement study ', Scandinavian Journal of Rheumatology, vol. 51, no. 1, pp. 25-33 . https://doi.org/10.1080/03009742.2021.1907925 Uhrenholt, L, Christensen, R, Dreyer, L, Schlemmer, A, Hauge, E-M, Krogh, N S, Abildtoft, M K, Taylor, P C & Kristensen, S 2022, ' Using a novel smartphone application for capturing of patient-reported outcome measures among patients with inflammatory arthritis: A randomized, crossover, agreement study ', Scandinavian Journal of Rheumatology, vol. 51, no. 1, pp. 25-33 . https://doi.org/10.1080/03009742.2021.1907925 Uhrenholt, L, Christensen, R, Dreyer, L, Schlemmer, A, Hauge, E-M, Krogh, NS, Abildtoft, MK, Taylor, PC & Kristensen, S 2022, ' Using a novel smartphone application for capturing of patient-reported outcome measures among patients with inflammatory arthritis:A randomized, crossover, agreement study ', Scandinavian Journal of Rheumatology, vol. 51, no. 1, pp. 25-33 . https://doi.org/10.1080/03009742.2021.1907925
Terslev, L, Ostergaard, M, Georgiadis, S, Brahe, C H, Ellegaard, K, Dohn, U M, Fana, V, Møller, T, Juul, L, Huynh, T K, Krabbe, S, Ornbjerg, L M, Glinatsi, D, Røgind, H, Hansen, A, Nørregaard, J, Jacobsen, S, Jensen, D V, Manilo, N, Asmussen, K, Boesen, M, Rastiemadabadi, Z, Morsel-Carlsen, L, Møller, J M, Krogh, N S & Hetland, M L 2022, ' Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care : characteristics and predictors ', RMD Open, vol. 8, no. 2 . https://doi.org/10.1136/rmdopen-2022-002796